Clinical Trial Update: Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rifaximin versus placebo for preventing traveler’s diarrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traveler Diarrhea

Drugs mentioned

• XIFAXAN (rifaximin)

Snippet

Sponsor: DuPont, Hurbert L., MD | Conditions: Diarrhea | Phase 2 | Status: COMPLETED